Novo Holdings
Investor profile
Private equityVenture capital
Novo Holdings has backed 46 European tech companies across 57 funding rounds between 2010 and 2026, joining rounds totalling €2.8B. Most active in Healthtech and Foodtech. Data as of Nov 2026.
Also recorded as: Novo · Novo Ventures
Deals
57
distinct rounds
Companies
46
backed
Active span
2010–2026
17 yrs
Total round €
€2.8B
sum of rounds joined
Deals by year
distinct rounds / yearNovo Holdings — deals by year — interactive chart.
Data table
| Novo Holdings — deals by year | |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 6 |
| 2025 | 10 |
| 2026 | 7 |
Top sectors
by dealsNovo Holdings — top sectors — interactive chart.
Data table
| Novo Holdings — top sectors | |
|---|---|
| Healthtech | 44 |
| Foodtech | 6 |
| Deeptech | 3 |
| Cleantech | 2 |
| Agritech | 1 |
| AI | 1 |
| Energy | 1 |
Stages
by dealsNovo Holdings — stages — interactive chart.
Data table
| Novo Holdings — stages | |
|---|---|
| Series A | 16 |
| Other | 14 |
| Series B | 10 |
| Series C | 8 |
| Seed | 6 |
| Series D+ | 2 |
| Early VC | 1 |
Countries
by dealsNovo Holdings — countries — interactive chart.
Data table
| Novo Holdings — countries | |
|---|---|
| Denmark | 24 |
| UK | 11 |
| Netherlands | 5 |
| Switzerland | 5 |
| France | 3 |
| Sweden | 3 |
| Germany | 2 |
| Ireland | 2 |
| Belgium | 1 |
| Finland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Sofinnova Partners6
- EIFO5
- Forbion5
- Athos Capital4
- Export and Investment Fund of Denmark (EIFO)4
- Andera Partners3
- Gilde Healthcare3
- GIMV3
- Industrifonden3
- INKEF Capital3
- OrbiMed3
- Sanofi Ventures3
- Seventure Partners3
- Sound Bioventures3
- Wellington Partners3
- Bpifrance2
- EQT Life Sciences2
- Eventide Asset Management2
- Glenview Capital2
- HealthCap2
- Innovestor Life Science Fund2
- Invest-NL2
- Investment Fund of Denmark (EIFO)2
- Invus2
- Ireland Strategic Investment Fund2
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| OMass Therapeutics | UK | 1 | €273M |
| Quanta | UK | 1 | €205M |
| Freeline Therapeutics | UK | 2 | €178M |
| Circtec | UK | 1 | €150M |
| Fire1 | Ireland | 2 | €139M |
| Amolyt Pharma | France | 1 | €129M |
| Hemab Therapeutics | Denmark | 1 | €127M |
| GlycoEra | Switzerland | 1 | €114M |
| Orbis Medicines | Denmark | 1 | €90M |
| 21st.BIO | Denmark | 1 | €86M |
| ObsEva | Switzerland | 2 | €80M |
| Antag Therapeutics | Denmark | 1 | €80M |
| Precirix | Belgium | 1 | €80M |
| AMSilk | Germany | 2 | €77M |
| Breye Therapeutics | Denmark | 2 | €72M |
| The Protein Brewery | Netherlands | 3 | €70M |
| Lava Therapeutics | Netherlands | 1 | €70M |
| F2G | UK | 1 | €69M |
| AnaCardio | Sweden | 1 | €63M |
| Bactolife | Denmark | 2 | €60M |
| Oxford Nanopore Technologies | UK | 1 | €59M |
| Quanta Dialysis Technologies | UK | 1 | €57M |
| Exscientia | UK | 1 | €55M |
| MinervaX | Denmark | 1 | €54M |
| Numab | Switzerland | 1 | €53M |
| Subra | Denmark | 1 | €40M |
| MATR Foods | Denmark | 1 | €40M |
| Evosep | Denmark | 1 | €37M |
| NMD Pharma | Denmark | 1 | €35M |
| Coave Therapeutics | France | 1 | €32M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Quanta | Series D+ | €205M | 2021-06 |
| Circtec | Other | €150M | 2024-05 |
| Amolyt Pharma | Series C | €129M | 2023-01 |
| Hemab Therapeutics | Series B | €127M | 2023-02 |
| Fire1 | Other | €115M | 2025-01 |
| GlycoEra | Series B | €114M | 2025-05 |
| Freeline Therapeutics | Series C | €107M | 2020-07 |
| Orbis Medicines | Series A | €90M | 2025-01 |
| 21st.BIO | Other | €86M | 2021-12 |
| Antag Therapeutics | Series A | €80M | 2024-12 |